Subtopic Deep Dive
Neurocognitive Outcomes in Moyamoya Disease
Research Guide
What is Neurocognitive Outcomes in Moyamoya Disease?
Neurocognitive outcomes in Moyamoya disease evaluate cognitive deficits, executive dysfunction, and quality of life changes in pediatric and adult patients before and after revascularization treatments using standardized neuropsychological batteries.
Studies show executive function most impaired in adults (Karzmark et al., 2008, 80 citations), while children exhibit deficits in intelligence and memory (Williams et al., 2011, 54 citations). Revascularization improves cognition post-surgery (Zeifert et al., 2017, 58 citations). Meta-analysis confirms deficits across domains in both age groups (Kronenburg et al., 2018, 64 citations). Over 10 key papers since 2008.
Why It Matters
Neurocognitive assessments guide patient selection for bypass surgery, as executive deficits predict functional outcomes (Karzmark et al., 2008). Post-revascularization improvements in cognition correlate with cerebral blood flow gains, informing treatment efficacy (Yanagihara et al., 2019). These outcomes shape holistic management, reducing stroke risk and enhancing quality of life (Weinberg et al., 2011). Data supports adult surgery benefits over medical therapy (Jang et al., 2016).
Key Research Challenges
Heterogeneity in Cognitive Deficits
Pediatric cases show broader impairments in IQ and memory compared to adults where executive function dominates (Williams et al., 2011; Karzmark et al., 2008). Standardized batteries vary across studies, complicating comparisons. Meta-analyses reveal modest to large effect sizes but call for determinant studies (Kronenburg et al., 2018).
Measuring Post-Surgical Changes
Revascularization yields variable cognitive gains, linked to blood flow but hard to quantify (Zeifert et al., 2017). Longitudinal data scarce; some patients decline postoperatively (Yanagihara et al., 2019). Lack of controls hinders isolating surgery effects from disease progression.
Correlating Ischemia to Profiles
Imaging-ischemia patterns poorly predict specific neuropsychological deficits (Weinberg et al., 2011). Few studies integrate MRI with testing batteries. Future work needs multimodal data to map profiles (Gonzalez et al., 2023).
Essential Papers
Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association
Nestor R. Gonzalez, Sepideh Amin‐Hanjani, Oh Young Bang et al. · 2023 · Stroke · 124 citations
Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. A writing group of experts was selected to conduct a literature search, summarize the current knowle...
EFFECT OF MOYAMOYA DISEASE ON NEUROPSYCHOLOGICAL FUNCTIONING IN ADULTS
Peter Karzmark, Penelope Zeifert, Simon Tan et al. · 2008 · Neurosurgery · 80 citations
The present findings suggest that moyamoya disease diagnosed in adults can impair cognition but that the effect is not as severe as in pediatric cases. Executive functioning is most affected. Memor...
Moyamoya disease: functional and neurocognitive outcomes in the pediatric and adult populations
David G. Weinberg, Rudy J. Rahme, Salah G. Aoun et al. · 2011 · Neurosurgical FOCUS · 75 citations
Object Moyamoya disease is an occlusive cerebrovascular disorder commonly resulting in neurocognitive impairment. The cognitive outcome parameters commonly affected are intelligence, memory, execut...
Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults
Dong‐Kyu Jang, Kwan‐Sung Lee, Hyoung Kyun Rha et al. · 2016 · Journal of neurosurgery · 72 citations
OBJECTIVE In this study the authors evaluated whether extracranial-intracranial bypass surgery can prevent stroke occurrence and decrease mortality in adult patients with symptomatic moyamoya disea...
Cognitive Functions in Children and Adults with Moyamoya Vasculopathy: A Systematic Review and Meta-Analysis
Annick Kronenburg, Esther van den Berg, Monique M. van Schooneveld et al. · 2018 · Journal of Stroke · 64 citations
s A large proportion of children and adults with MMV have cognitive impairment, with modest to large deficits across various cognitive domains. Further studies should investigate determinants of co...
Direct versus indirect revascularization in the treatment of moyamoya disease
Seong-eun Park, Ju-seong Kim, Eun-Kyung Park et al. · 2017 · Journal of neurosurgery · 62 citations
OBJECTIVE For patients with moyamoya disease (MMD), surgical intervention is usually required because of progressive occlusion of the internal carotid artery. The indirect bypass method has been wi...
Neurocognitive Performance After Cerebral Revascularization in Adult Moyamoya Disease
Penelope Zeifert, Peter Karzmark, Teresa Bell‐Stephens et al. · 2017 · Stroke · 58 citations
Background and Purpose— Cerebral revascularization using EC-IC bypass is widely used to treat moyamoya disease, but the effects of surgery on cognition are unknown. We compared performance on forma...
Reading Guide
Foundational Papers
Start with Karzmark et al. (2008, 80 citations) for adult executive deficits baseline, Weinberg et al. (2011, 75 citations) for pediatric/adult comparisons, Williams et al. (2011, 54 citations) for vasculopathy intellect specifics.
Recent Advances
Study Zeifert et al. (2017, 58 citations) for revascularization cognition gains, Kronenburg et al. (2018, 64 citations) meta-analysis, Yanagihara et al. (2019, 48 citations) blood flow links.
Core Methods
Neuropsychological batteries (WAIS-IV, WMS, D-KEFS), pre/post-testing around EC-IC bypass, meta-regression for domains (Kronenburg et al., 2018; Zeifert et al., 2017).
How PapersFlow Helps You Research Neurocognitive Outcomes in Moyamoya Disease
Discover & Search
Research Agent uses searchPapers on 'neurocognitive outcomes Moyamoya' to retrieve Karzmark et al. (2008, 80 citations), then citationGraph maps forward citations to Zeifert et al. (2017), and findSimilarPapers expands to pediatric meta-analysis by Kronenburg et al. (2018). exaSearch drills into 'executive dysfunction post-revascularization adults' for Jang et al. (2016).
Analyze & Verify
Analysis Agent applies readPaperContent to Zeifert et al. (2017) for pre/post-surgery scores, verifyResponse with CoVe cross-checks claims against Gonzalez et al. (2023). runPythonAnalysis meta-analyzes deficit sizes from Kronenburg et al. (2018) using pandas for effect sizes, with GRADE grading rates evidence as moderate for executive function claims.
Synthesize & Write
Synthesis Agent detects gaps like pediatric-adult comparisons missing in recent reviews, flags contradictions between Karzmark et al. (2008) adult sparing and Williams et al. (2011) pediatric impacts. Writing Agent uses latexEditText for outcome tables, latexSyncCitations integrates 10 papers, latexCompile generates report, exportMermaid diagrams ischemia-cognition flows.
Use Cases
"Meta-analyze cognitive effect sizes from Moyamoya papers using Python."
Research Agent → searchPapers 'cognitive meta-analysis Moyamoya' → Analysis Agent → runPythonAnalysis (pandas forest plot on Kronenburg 2018 data) → outputs CSV of standardized mean differences with CI.
"Draft LaTeX review on revascularization cognitive outcomes."
Synthesis Agent → gap detection (post-surgery gaps) → Writing Agent → latexEditText (intro/outcomes sections) → latexSyncCitations (Zeifert 2017, Yanagihara 2019) → latexCompile → PDF with figures.
"Find code for analyzing Moyamoya neurocognitive datasets."
Research Agent → paperExtractUrls (neuropsych data papers) → paperFindGithubRepo → githubRepoInspect → outputs R scripts for executive function scoring from Williams et al. (2011)-linked repos.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers 50+ papers on outcomes → DeepScan 7-step verifies claims in Karzmark (2008) → structured report with GRADE scores. Theorizer generates hypotheses linking ischemia to executive deficits from Zeifert (2017) and Yanagihara (2019). DeepScan applies CoVe checkpoints to post-surgery data chains.
Frequently Asked Questions
What defines neurocognitive outcomes in Moyamoya disease?
Outcomes assess deficits in executive function, memory, IQ, and quality of life using batteries like WAIS, pre/post-treatment (Karzmark et al., 2008; Weinberg et al., 2011).
What methods evaluate these outcomes?
Standardized tests include executive batteries (Trail Making), memory (WMS), IQ (WAIS), applied longitudinally around revascularization (Zeifert et al., 2017; Kronenburg et al., 2018).
What are key papers?
Karzmark et al. (2008, 80 citations) on adult deficits; Williams et al. (2011, 54 citations) on pediatric IQ; Zeifert et al. (2017, 58 citations) on surgery effects.
What open problems exist?
Determinants of deterioration, imaging-cognition correlations, long-term post-surgery trajectories need study (Kronenburg et al., 2018; Gonzalez et al., 2023).
Research Moyamoya disease diagnosis and treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Neurocognitive Outcomes in Moyamoya Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers